Author
Gular Mammadli
0 works0 citations
Recent research
- Health & MedicineOpen access
Abstract Background While guidelines recommend andexanet alfa (AA) for reversing factor Xa (FXa) inhibitors, its high cost and thrombotic risk have led to off-label use of 4-factor prothrombin complex concentrate (4F-PCC), despite limited comparative data. This comparative effect...